Nuclear factor of activated T cells (NFAT) signaling regulates PTEN expression and intestinal cell differentiation

Molecular Biology of the Cell

Volumn 22, Issue 3, 2011, Pages 412-420

  Wang, Qingding ^a,b   Zhou, Yuning ^b   Jackson, Lindsey N ^c   Johnson, Sara M ^c   Chow, Chi Wing ^d   Evers, B Mark ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLOSPORIN A; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN NFATC1; PROTEIN NFATC2; PROTEIN NFATC3; PROTEIN NFATC4; PROTEIN P27; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HT29 CELLS; HUMANS; NFATC TRANSCRIPTION FACTORS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 79551672591     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-07-0598     Document Type: Article

References (52)

1. Aurora AB, Biyashev D, Mirochnik Y, Zaichuk TA, Sanchez-Martinez C, Renault MA, Losordo D, Volpert OV ( 2010). NF-κB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood 116, 475-484.
2. Caetano MS, Vieira-de-Abreu A, Teixeira LK, Werneck MB, Barcinski MA, Viola JP ( 2002). NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J 16, 1940-1942.
3. Cantley LC, Neel BG ( 1999). New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96, 4240-4245.
4. Cheng H, Leblond CP ( 1974). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 141, 537-561.
5. de la Pompa JL et al. ( 1998). Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392, 182-186. (Pubitemid 28162791)
6. Decker EL, Nehmann N, Kampen E, Eibel H, Zipfel PF, Skerka C ( 2003). Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res 31, 911-921. (Pubitemid 36240429)
7. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD ( 2000). A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 20, 6600-6611.
8. Deschenes C, Vezina A, Beaulieu JF, Rivard N ( 2001). Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology 120, 423-438. (Pubitemid 32147640)
9. Ding Q, Wang Q, Evers BM ( 2001). Alterations of MAPK activities associated with intestinal cell differentiation. Biochem Biophys Res Commun 284, 282-288. (Pubitemid 32917972)
10. Ding QM, Ko TC, Evers BM ( 1998). Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol 275, C1193-C1200.
11. Duque J, Fresno M, Iniguez MA ( 2005). Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 280, 8686-8693.
12. Ewton DZ, Kansra S, Lim S, Friedman E ( 2002). Insulin-like growth factor-I has a biphasic effect on colon carcinoma cells through transient inactivation of forkhead1, initially mitogenic, then mediating growth arrest and differentiation. Int J Cancer 98, 665-673.
13. Farrow B, Evers BM ( 2003). Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. Biochem Biophys Res Commun 301, 50-53. (Pubitemid 36268846)
14. Gafter-Gvili A, Sredni B, Gal R, Gafter U, Kalechman Y ( 2003). Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes. Am J Physiol Cell Physiol 284, C1593-1603.
15. Ghosh-Choudhury N, Mandal CC, Ghosh Choudhury G ( 2010). Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth. Cell Signal 22, 749-758.
16. Ho IC, Kim JH, Rooney JW, Spiegelman BM, Glimcher LH ( 1998). A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis. Proc Natl Acad Sci USA 95, 15537-15541.
17. Hogan PG, Chen L, Nardone J, Rao A ( 2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17, 2205-2232.
18. Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA, Crabtree GR ( 2009). Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323, 651-654.
19. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM ( 2004). Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-α/nuclear factor-κB (NF-κB)-inducing kinase/NF-κB pathway is linked to a default IκB-α autoregulatory loop. J Biol Chem 279, 4285-4291.
20. Kim S, Domon-Dell C, Wang Q, Chung DH, Di Cristofano A, Pandolfi PP, Freund JN, Evers BM ( 2002). PTEN and TNF-α regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-κB-dependent pathway. Gastroenterology 123, 1163-1178.
21. Lee M, Park J ( 2006). Regulation of NFAT activation: a potential therapeutic target for immunosuppression. Mol Cells 22, 1-7.
22. Liang J, Slingerland JM ( 2003). Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2, 339-345.
23. Lin H, Sue YM, Chou Y, Cheng CF, Chang CC, Li HF, Chen CC, Juan SH ( 2010). Activation of a nuclear factor of activated T-lymphocyte-3 (NFAT3) by oxidative stress in carboplatin-mediated renal apoptosis. Br J Pharmacol 161, 1661-1676.
24. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN ( 1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228. (Pubitemid 28180855)
25. Ortega-Perez I, Cano E, Were F, Villar M, Vazquez J, Redondo JM ( 2005). c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain. J Biol Chem 280, 20867-20878. (Pubitemid 40776792)
26. Park S et al. ( 2009). RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res 69, 4107-4111.
27. Patra AK, Drewes T, Engelmann S, Chuvpilo S, Kishi H, Hunig T, Serfling E, Bommhardt UH ( 2006). PKB rescues calcineurin/NFAT-induced arrest of Rag expression and pre-T cell differentiation. J Immunol 177, 4567-4576.
28. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A ( 2004). Rational siRNA design for RNA interference. Nat Biotechnol 22, 326-330.
29. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP ( 2008). Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 28, 7168-7181.
30. Santini MP, Talora C, Seki T, Bolgan L, Dotto GP ( 2001). Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci USA 98, 9575-9580.
31. Shen YH, Zhang L, Gan Y, Wang X, Wang J, LeMaire SA, Coselli JS, Wang XL ( 2006). Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells. J Biol Chem 281, 7727-7736.
32. Shioda N, Han F, Moriguchi S, Fukunaga K ( 2007). Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia. J Neurochem 102, 1506-1517.
33. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H ( 1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96, 6199-6204.
34. Tamguney T, Stokoe D ( 2007). New insights into PTEN. J Cell Sci 120, 4071-4079.
35. Traber PG ( 1994). Differentiation of intestinal epithelial cells: lessons from the study of intestine-specific gene expression. J Lab Clin Med 123, 467-477.
36. Ueffing N, Schuster M, Keil E, Schulze-Osthoff K, Schmitz I ( 2008). Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells. Blood 112, 690-698.
37. Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F, Foti M ( 2008). PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-κBp65/ mTOR-dependent mechanism. Gastroenterology 134, 268-280.
38. Viola JP, Carvalho LD, Fonseca BP, Teixeira LK ( 2005). NFAT transcription factors: from cell cycle to tumor development. Braz J Med Biol Res 38, 335-344.
39. Wang Q, Wang X, Evers BM ( 2003). Induction of cIAP-2 in human colon cancer cells through PKCδ/NF-κB. J Biol Chem 278, 51091-51099. (Pubitemid 38020344)
40. Wang Q, Wang X, Hernandez A, Kim S, Evers BM ( 2001). Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroenterology 120, 1381-1392.
41. Wang Q, Zhou Y, Wang X, Chung DH, Evers BM ( 2007). Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-terminal kinase activation and nuclear factor-κB inhibition. Cancer Res 67, 7773-7781.
42. Wang Q, Zhou Y, Wang X, Evers BM ( 2006). Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25, 43-50.
43. Wang Q, Zhou Y, Wang X, Evers BM ( 2008). p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells. Cell Death Differ 15, 908-919.
44. Wilson CA, Browning JL ( 2002). Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 9, 1321-1333.
45. Wu CC, Hsu SC, Shih HM, Lai MZ ( 2003). Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells. Mol Cell Biol 23, 6442-6454.
46. Wu H, Peisley A, Graef IA, Crabtree GR ( 2007). NFAT signaling and the invention of vertebrates. Trends Cell Biol 17, 251-260.
47. Yang TT, Chow CW ( 2003). Transcription cooperation by NFAT.C/EBP composite enhancer complex. J Biol Chem 278, 15874-15885.
48. Yang TT et al. ( 2006). Role of transcription factor NFAT in glucose and insulin homeostasis. Mol Cell Biol 26, 7372-7387.
49. Yang TT, Xiong Q, Enslen H, Davis RJ, Chow CW ( 2002). Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol Cell Biol 22, 3892-3904.
50. Yao K, Cho YY, Bergen HR 3rd, Madden BJ, Choi BY, Ma WY, Bode AM, Dong Z ( 2007). Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation. Cancer Res 67, 8725-8735.
51. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A ( 2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20, 539-550. (Pubitemid 41668639)
52. Yoshida H et al. ( 1998). The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8, 115-124.